SOPH Form 144: Insider Plans Sale of 6,833 Shares ($30.5K)

SOPHiA GENETICS SA (SOPH) filing a Form 144 notifies a proposed sale of 6,833 common shares with an aggregate market value of $30,543.51 to be sold approximately on 10/03/2025 on NASDAQ.

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) filing a Form 144 notifies a proposed sale of 6,833 common shares with an aggregate market value of $30,543.51 to be sold approximately on 10/03/2025 on NASDAQ. The shares were acquired as Restricted Stock Units on 10/02/2025 from the issuer and payment was recorded on 10/02/2025. The filing shows the seller previously completed Rule 10b5-1 sales totaling 5,337 shares across five transactions from 07/07/2025 through 09/19/2025, generating gross proceeds shown per transaction. The Form 144 includes the seller's representation that no undisclosed material adverse information exists and conforms to Rule 144 disclosure requirements.

Positive

• Compliance with Rule 144 filing for proposed sale of 6,833 shares (aggregate $30,543.51)
• Acquisition documented as Restricted Stock Units on 10/02/2025, showing clear basis for sale eligibility

Negative

• Insider selling activity: prior Rule 10b5-1 sales of 5,337 shares between 07/07/2025 and 09/19/2025
• Sale size relative to outstanding shares: 6,833 vs 67,579,560 outstanding (small but disclosed insider liquidation)

Insights

Equity Compensation Analyst

TL;DR: Insider intends to sell newly vested 6,833 RSU shares worth $30,543.51 on or about 10/03/2025.

The filing discloses that the securities were acquired as Restricted Stock Units on 10/02/2025, indicating a recent vesting or issuance event explicitly documented in the notice. The planned sale is being reported under Rule 144, which is the standard compliance path for restricted or control securities becoming eligible for public sale.

The archive of Rule 10b5-1 sales shows the same account sold 5,337 shares in five transactions between 07/07/2025 and 09/19/2025, with per-transaction gross proceeds listed in the filing. That history confirms recent, disclosed offloading activity by the same holder.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the amount of SOPH shares proposed for sale in the Form 144?

The Form 144 reports a proposed sale of 6,833 common shares with an aggregate market value of $30,543.51.

When were the shares to be sold acquired according to the filing?

The shares were acquired as Restricted Stock Units on 10/02/2025, with payment recorded on the same date.

On what date is the planned sale scheduled?

The approximate date of sale listed is 10/03/2025 on NASDAQ.

Does the filing show prior sales by the same person?

Yes. The filing lists five Rule 10b5-1 sales totaling 5,337 shares between 07/07/2025 and 09/19/2025, with gross proceeds per transaction disclosed.

What assurance does the seller provide about undisclosed information?

By signing the notice, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006362
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	ZHENYU XU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6833	30543.51	67579560	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Restricted Stock Units	Issuer			6833	10/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	09/19/2025	608	1933.74
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	08/19/2025	609	2091.61
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/23/2025	105	360.15
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2025	609	2153.97
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2025	3406	10321.54

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 10/02/2025 through 12/18/2025.
Date of Notice	10/03/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Zhenyu Xu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)